GABAA/Benzodiazepine receptor binding in patients with schizophrenia using [11C]Ro15-4513, a radioligand with relatively high affinity for α5 subunit

Dysfunction of the GABA system is considered to play a role in the pathology of schizophrenia. Individual subunits of GABA(A)/Benzodiazepine (BZ) receptor complex have been revealed to have different functional properties. alpha5 subunit was reported to be related to learning and memory. Changes of alpha5 subunit in schizophrenia were reported in postmortem studies, but the results were inconsistent. In this study, we examined GABA(A)/BZ receptor using [(11)C]Ro15-4513, which has relatively high affinity for alpha5 subunit, and its relation to clinical symptoms in patients with schizophrenia. [(11)C]Ro15-4513 bindings of 11 patients with schizophrenia (6 drug-naïve and 5 drug-free) were compared with those of 12 age-matched healthy control subjects using positron emission tomography. Symptoms were assessed using the Positive and Negative Syndrome Scale. [(11)C]Ro15-4513 binding was quantified by binding potential (BP) obtained by the reference tissue model. [(11)C]Ro15-4513 binding in the prefrontal cortex and hippocampus was negatively correlated with negative symptom scores in patients with schizophrenia, although there was no significant difference in BP between patients and controls. GABA(A)/BZ receptor including alpha5 subunit in the prefrontal cortex and hippocampus might be involved in the pathophysiology of negative symptoms of schizophrenia.

[1]  P. McKenna,et al.  Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABAA receptor α-1 subunit messenger RNA and human GABA transporter-1 (hGAT-1) messenger RNA expression , 1999, Neuroscience.

[2]  A. Guidotti,et al.  GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon , 2005, Psychopharmacology.

[3]  S. Akbarian,et al.  GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. , 1995, Cerebral cortex.

[4]  R. Kerwin,et al.  Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. , 1997, The American journal of psychiatry.

[5]  E A Barnard,et al.  International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. , 1998, Pharmacological reviews.

[6]  E. Bullmore,et al.  Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia. , 2007, Archives of general psychiatry.

[7]  A. Guidotti,et al.  Imidazenil and diazepam increase locomotor activity in mice exposed to protracted social isolation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Yoshiyuki Asai,et al.  Quantitative analyses of [11C]Ro15-4513 binding to subunits of GABAA/benzodiazepine receptor in the living human brain , 2009, Nuclear medicine communications.

[9]  U. Rudolph,et al.  GABA(A)-receptor subtypes: a new pharmacology. , 2001, Current opinion in pharmacology.

[10]  P. Seeburg,et al.  Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors. , 1994, Molecular pharmacology.

[11]  Victor W. Pike,et al.  Imaging the GABA-Benzodiazepine Receptor Subtype Containing the α5-Subunit In Vivo with [11C]Ro15 4513 Positron Emission Tomography , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  T. Rülicke,et al.  Molecular and neuronal substrate for the selective attenuation of anxiety. , 2000, Science.

[13]  Arthur P. Shimamura,et al.  Memory and frontal lobe function. , 1995 .

[14]  A. Sampson,et al.  Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. , 2002, Cerebral cortex.

[15]  J. Krystal,et al.  [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia , 1999, Psychiatry Research: Neuroimaging.

[16]  John Seibyl,et al.  No Evidence of Altered In Vivo Benzodiazepine Receptor Binding in Schizophrenia , 1999, Neuropsychopharmacology.

[17]  P. Seeburg,et al.  GABAA/Benzodiazepine receptor heterogeneity: Neurophysiological implications , 1995, Neuropharmacology.

[18]  B. Dean,et al.  Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. , 1999, Journal of neurochemistry.

[19]  J. Baron,et al.  Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography. , 1992, European journal of pharmacology.

[20]  Yoshiro Okubo,et al.  Memory and frontal lobe functions; possible relations with dopamine D2 receptors in the hippocampus , 2007, NeuroImage.

[21]  T. Asada,et al.  Immunohistochemical and immunoblot study of GABAA α1 and β2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder , 2004, Neuroscience Research.

[22]  F. Benes,et al.  Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain , 1996, Synapse.

[23]  M. Ticku,et al.  An update on GABAA receptors , 1999, Brain Research Reviews.

[24]  G. Johnston,et al.  The effects of antipsychotic drugs on GABAA receptor binding depend on period of drug treatment and binding site examined , 2007, Schizophrenia Research.

[25]  M. Iyo,et al.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET , 1997, Nature.

[26]  Tetsuya Suhara,et al.  In vivo binding of [11C]Ro15-4513 in human brain measured with PET , 1992, Neuroscience Letters.

[27]  Steven H. Jones,et al.  Cognitive functioning and GABAA/benzodiazepine receptor binding in schizophrenia: A 1231-iomazenil SPET study , 1998, Biological Psychiatry.

[28]  Tetsuya Suhara,et al.  Visualization of α5 subunit of GABAA/benzodiazepine receptor by [11C]Ro15‐4513 using positron emission tomography , 2003 .

[29]  R. V. Van Heertum,et al.  Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.

[30]  J. Glowinski,et al.  Influence of the hippocampus on interneurons of the rat prefrontal cortex , 2004, The European journal of neuroscience.

[31]  P. Goldman-Rakic,et al.  Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey , 1984, Neuroscience.

[32]  J. Baron,et al.  Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PET , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[34]  J. Sangiovanni,et al.  Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  J. Pierri,et al.  Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia , 1999, Biological Psychiatry.

[36]  G. Reynolds,et al.  Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia , 1990, Biological Psychiatry.

[37]  O. Inoue,et al.  No age-related changes in human benzodiazepine receptor binding measured by PET with [11C]Ro 15-4513 , 1993, Neuroscience Letters.

[38]  D. Lewis,et al.  Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction , 2004, Psychopharmacology.

[39]  S Laroche,et al.  Plasticity at hippocampal to prefrontal cortex synapses: Dual roles in working memory and consolidation , 2000, Hippocampus.

[40]  G. Sedvall,et al.  [11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding , 1992, Psychopharmacology.

[41]  J. Deakin,et al.  Reduced GABA uptake sites in the temporal lobe in schizophrenia , 1989, Neuroscience Letters.

[42]  G. Dawson,et al.  Identification of a Novel, Selective GABAA α5 Receptor Inverse Agonist Which Enhances Cognition , 2003 .

[43]  F. Benes,et al.  Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects , 1996, Neuroscience.

[44]  R. Buckner,et al.  Changing frontal contributions to memory before and after medial temporal lobectomy. , 2006, Cerebral cortex.

[45]  H. Wieland,et al.  Four amino acid exchanges convert a diazepam-insensitive, inverse agonist-preferring GABAA receptor into a diazepam-preferring GABAA receptor. , 1994, Journal of medicinal chemistry.

[46]  A. D. De Blas,et al.  Synaptic and nonsynaptic localization of GABAA receptors containing the α5 subunit in the rat brain , 2006 .

[47]  F. Kuenzi,et al.  Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor , 2002, The Journal of Neuroscience.

[48]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[49]  S. Moss,et al.  Constructing inhibitory synapses , 2001, Nature Reviews Neuroscience.

[50]  Yogesh K. Dwivedi,et al.  A decrease of reelin expression as a putative vulnerability factor in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Toshihito Suzuki,et al.  Differential expression of GABAA receptor subunit mRNAs and ligand binding sites in rat brain following phencyclidine administration , 2000, Synapse.

[52]  G. González-Burgos,et al.  Pathophysiologically based treatment interventions in schizophrenia , 2006, Nature Medicine.

[53]  M. Mandelli,et al.  Molecular targets for the myorelaxant action of diazepam. , 2001, Molecular pharmacology.